← Back to headlines
Abivax CEO Confident in June Trial Data for Better Deal Terms
Abivax CEO stated to CNBC that the company is not rushing for a deal, confident that key June trial data will enable them to secure better terms for potential partnerships, amidst analyst speculation of a takeover, reiterating no urgency for deal-making ahead of the readout.
24 Mar, 15:42 — 24 Mar, 17:04
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (27/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left1
Left (1)
cnbc
Center
Right1
Right (1)
seeking-alpha
Far R
Geographic diversity— 1 region4/34
US2
ℹAll sources from US region
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
cnbcMostly Factual4d ago
Abivax in no rush for a deal, confident key June trial data can secure better terms for partnerships, CEO tells CNBC
Analysts see the biotech company as a prime takeover target and several pharma giants have been rumored as potential buyers.
Read full article →seeking-alphaMixed4d ago
Abivax CEO suggests no urgency for deal-making ahead of key trial readout
Read full article →Coverage Timeline
First report: cnbc · 24 Mar, 15:42|Full coverage: 2 · 1h|Window: 1h
Left-leaningCenterRight-leaning
Related Stories
Philippine Lawmaker Urges Government to Build Coastal Petroleum Storage Facilities
just now
DICT Pledges Wider Free Internet Access on Philippines' 32nd Connectivity Anniversary
just now
Philippine SSS Considers Loan Relief and Condonation Programs
just now
Bank of America to Pay $72.5 Million Settlement in Epstein Lawsuit
10m ago